Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways.
A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback